Portfolio trading has surged among fixed income investors in recent years. This analysis explores how its performance ...

Merck is a strong and profitable pick meeting Benjamin Graham's criteria. Read more on why investors need to stay aware of ...

Q2 2025 Management View CEO H. Palmer Proctor highlighted a "20-plus percent annualized revenue growth in the quarter, which ...

EVERETT, Wash., July 29, 2025 (GLOBE NEWSWIRE) -- Coastal Financial Corporation (Nasdaq: CCB) (the“Company”, "Coastal", "we", ...

AGNC Investment Corp. (NASDAQ:AGNC) is included among the 10 Stocks with Highest Dividend to Buy Right Now. AGNC Investment Corp. (NASDAQ:AGNC), a mortgage REIT focused on agency-backed ...

When we feel we are heading into a recession or the market is fully valued, we look at consumer defensive stocks ...

What if there was a way for you to benefit from value investing without any need to research hundreds of stocks by yourself?

Anthem Biosciences share price made a strong debut on the bourses today. On NSE, Anthem Biosciences share price opened at ₹723.05 per share, 26.85% higher than the issue price of ₹570. On BSE ...

Book value per common share decreased to $11.95 from $12.56 in Q1, while the company reported a comprehensive loss of $0.11 per share compared to income of $0.16 in the previous quarter.

iTeos Therapeutics Enters into Agreement to Be Acquired by Concentra Biosciences for $10.047 in Cash per Share Plus a Contingent Value Right ...

WATERTOWN, Mass. and GOSSELIES, Belgium, July 21, 2025 (GLOBE NEWSWIRE) — iTeos Therapeutics, Inc. (“iTeos”) (Nasdaq: ITOS) today announced that it has entered into a definitive merger agreement ...

WATERTOWN, Mass. and GOSSELIES, Belgium, July 21, 2025 (GLOBE NEWSWIRE) -- iTeos Therapeutics, Inc. ("iTeos”) (Nasdaq: ITOS) today announced that it has entered into a definitive merger agreement ...